US & World

Johnson and Johnson COVID Boosters on Friday’s FDA Panel Agenda

Earlier this week, a US study suggested that Johnson & Johnson vaccinated people would receive even stronger protection when they took booster shots from Moderna or Pfizer.

Washington — USA Health adviser will meet on Friday Discuss with Johnson & Johnson’s COVID-19 Vaccine Booster whether it is safe to take booster shots from a different brand than the first vaccine.

The Food and Drug Administration’s Advisory Board unanimously voted Thursday recommending Moderna booster shots for older people and adults with other health problems, work, or living conditions that increase the risk of COVID-19. ..

Earlier this week, a US study found that Johnson & Johnson vaccinated people should get booster shots from Moderna or Pfizer. NS Preliminary research on “mixing and matching” The National Institute of Allergy and Infectious Diseases reported that those who received the first J & J vaccine benefited from the second dose, but showed even higher immune responses with boosters from different brands.

Friday’s FDA advisor will discuss the results of the study and whether mixing and matching are safe and effective.

Currently, for certain Americans, the Pfizer-BioNTech Booster Vaccine is the only FDA thumbs up. Moderna requested the FDA to approve the booster shot six months after the second dose, similar to Pfizer’s request.

Johnson & Johnson requested approval for booster immunization two months after the single-dose vaccine.

This week’s meeting is the first step in the approval process. Based on the advisory board’s recommendations, the FDA will decide whether to approve the booster. The Centers for Disease Control and Prevention then has the final say.

The Associated Press contributed to this report.

Johnson and Johnson COVID Boosters on Friday’s FDA Panel Agenda

Source link Johnson and Johnson COVID Boosters on Friday’s FDA Panel Agenda

Related Articles

Back to top button